Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,634 | -15,260 | -9,528 | -3,897 | -20,251 |
| Depreciation Amortization | 94 | 77 | 53 | 27 | 119 |
| Accounts receivable | 123 | -24 | -84 | -64 | -786 |
| Accounts payable and accrued liabilities | 1,914 | 2,826 | 1,196 | 290 | 521 |
| Other Working Capital | 2,103 | 2,749 | 1,501 | 348 | 318 |
| Other Operating Activity | -1,786 | -2,622 | -2,185 | -1,336 | -1,300 |
| Operating Cash Flow | $-16,186 | $-12,254 | $-9,047 | $-4,632 | $-21,379 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -22 | -14 | N/A | -67 |
| Investing Cash Flow | $-22 | $-22 | $-14 | $N/A | $-67 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -76 | -58 | -26 | -19 | -74 |
| Common Stock Issued | 14,159 | 12,008 | 6,088 | 6,088 | 16,664 |
| Other Financing Activity | 1,697 | 1,697 | 1,697 | 0 | 0 |
| Financing Cash Flow | $15,780 | $13,647 | $7,759 | $6,069 | $16,590 |
| Beginning Cash Position | 1,535 | 1,535 | 1,535 | 1,535 | 6,391 |
| End Cash Position | 1,107 | 2,906 | 233 | 2,972 | 1,535 |
| Net Cash Flow | $-428 | $1,371 | $-1,302 | $1,437 | $-4,856 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,186 | -12,254 | -9,047 | -4,632 | -21,379 |
| Capital Expenditure | -22 | -22 | -14 | N/A | -67 |
| Free Cash Flow | -16,208 | -12,276 | -9,061 | -4,632 | -21,446 |